Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunities

C Hu, J Yang, Z Qi, H Wu, B Wang, F Zou, H Mei… - MedComm, 2022 - Wiley Online Library
The heat shock proteins (HSPs) are ubiquitous and conserved protein families in both
prokaryotic and eukaryotic organisms, and they maintain cellular proteostasis and protect …

Induced protein degradation: an emerging drug discovery paradigm

AC Lai, CM Crews - Nature reviews Drug discovery, 2017 - nature.com
Small-molecule drug discovery has traditionally focused on occupancy of a binding site that
directly affects protein function, and this approach typically precludes targeting proteins that …

HSP90 inhibitors and cancer: Prospects for use in targeted therapies

ZN Li, Y Luo - Oncology reports, 2022 - spandidos-publications.com
Heat shock protein 90 (HSP90) is a vital chaperone protein, regulating signaling pathways
and correcting misfolded proteins in cancer cells by interacting with oncogenic client …

Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development

Q Wan, D Song, H Li, M He - Signal transduction and targeted therapy, 2020 - nature.com
Stress proteins (SPs) including heat-shock proteins (HSPs), RNA chaperones, and ER
associated stress proteins are molecular chaperones essential for cellular homeostasis. The …

Treatment of HER2-positive breast cancer: current status and future perspectives

CL Arteaga, MX Sliwkowski, CK Osborne… - Nature reviews Clinical …, 2012 - nature.com
The advent of HER2-directed therapies has significantly improved the outlook for patients
with HER2-positive early stage breast cancer. However, a significant proportion of these …

Old and new approaches to target the Hsp90 chaperone

J Sanchez, TR Carter, MS Cohen… - Current cancer drug …, 2020 - ingentaconnect.com
The 90-kDa heat shock protein (Hsp90) is a molecular chaperone that ensures cellular
proteostasis by maintaining the folding, stabilization, activation, and degradation of over 400 …

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

P Magnaghi, R D'alessio, B Valsasina, N Avanzi… - Nature chemical …, 2013 - nature.com
VCP (also known as p97 or Cdc48p in yeast) is an AAA+ ATPase regulating endoplasmic
reticulum–associated degradation. After high-throughput screening, we developed …

[HTML][HTML] Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers

K Jhaveri, T Taldone, S Modi, G Chiosis - Biochimica et Biophysica Acta …, 2012 - Elsevier
Hsp90 is an ATP dependent molecular chaperone protein which integrates multiple
oncogenic pathways. As such, Hsp90 inhibition is a promising anti-cancer strategy. Several …

Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies

M Broekgaarden, R Weijer, TM van Gulik… - Cancer and Metastasis …, 2015 - Springer
Photodynamic therapy (PDT) has emerged as a promising alternative to conventional
cancer therapies such as surgery, chemotherapy, and radiotherapy. PDT comprises the …

HSP90 inhibitors: current development and potential in cancer therapy

K Sidera, E Patsavoudi - Recent patents on anti-cancer drug …, 2014 - ingentaconnect.com
In the last decade, the molecular chaperone HSP90 has emerged as an important target in
cancer therapeutics and has subsequently become the focus of several drug discovery and …